Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$25.30 USD
-0.20 (-0.78%)
Updated Nov 3, 2025 03:59 PM ET
After-Market: $25.28 -0.02 (-0.08%) 4:50 PM ET
3-Hold of 5 3
A Value D Growth D Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Amphastar Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Generic Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AMPH 25.30 -0.20(-0.78%)
Will AMPH be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for AMPH based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for AMPH
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?
Taysha Gene Therapies, Inc. (TSHA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
AMPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Preview: Amphastar Pharmaceuticals (AMPH) Q2 Earnings Expected to Decline
What Makes Amphastar (AMPH) a New Buy Stock
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Other News for AMPH
AMPH forms 20 Day Moving Average Support on October 31
Is AMPH primed for upward momentum? Crossed Above 20 Day Moving Average shows up after advancing 1.73%
AMPH forms 20 Day Moving Average Resistance on October 29
AMPH's price rises by 0.58% on October 28, though its technical setup remains stable.
The technical outlook for AMPH is unchanged after it falls 1.96% on October 27